April 24, 2006
New York Times
The drug maker Wyeth posted a 4 percent increase in first-quarter profit Friday, citing cost controls and large increases in sales for five popular drugs, including Effexor, the company's top-selling antidepressant.
more...
March 27, 2006
Dr. Leo Lutwak, a biochemist and nutritionist who raised early concerns about health risks from the diet aid fen-phen while he was a medical officer for the Food and Drug Administration, died on Feb. 23 at a hospital in Maryland. He was 77 and lived in Silver Spring, Md.
more...
March 13, 2006
The following are files related to the ongoing fen-phen litigation in which our firm is involved. Updates are made regularly, so check back often for new files.
more...
May 08, 2005
A new tax break for corporations is allowing the biggest American drug makers to return as much as $75 billion in profits from international havens to the United States while paying a fraction of the normal tax rate.
The break is part of the American Jobs Creation Act, signed into law by President Bush in October, which allows companies a one-year window to return foreign profits to the United States at a 5.25 percent tax rate, compared with the standard 35 percent rate.
more...
